Recent Articles from GlobeNewswire

CRYOPDP, part of DHL Health Logistics, wins SAP Digital Transformation Award for blockchain-based platform built on Silent Data by Applied Blockchain

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the Evercore 8th Annual Healthcare Conference on Thursday in Miami.

Pluristyx to lead a new public-private consortium with 9 other industry leaders to establish global standards for non-animal drug testing models

SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and neurodegenerative diseases, today announced that the Company added two leading experts to their advisory board and provided an update to its ongoing Phase 2 study of VTX2735 in patients with recurrent pericarditis (“RP”).

CEBU CITY, Philippines, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Entering the United States market promises great opportunities for an international business, but doing so correctly and maintaining compliance can be riddled with challenges. With more businesses trying to enter the largest buying market in the world, the need for expert guidance and direction will continue to be in demand.

Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment

GOLETA, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, today announced that its CEO Jonathan Klamkin, Ph.D., and CFO Christopher Stewart will participate in the Northland Growth Conference on December 16, 2025. The format will be virtual one-on-ones and small group meetings.

The appointment strengthens platform-wide communications as Stewards advances in private credit, real assets and digital finance

VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) is pleased to provide a corporate update following its recently released Q3 financial results and investor webinar.

Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce further positive high-grade oxide antimony drill results from surface at the newly discovered antimony-gold “Bullet Zone” at its Limousine Butte Project (the “Project”, “Limo Butte”) in Nevada. The Bullet Zone was discovered in the 2025 drill program with step-out drilling testing NevGold’s new geology model at the Project. The Bullet Zone discovery significantly expands the gold-antimony mineralization footprint at the Resurrection Ridge target, which NevGold is advancing to an initial gold-antimony Mineral Resource Estimate (“MRE”).

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, today announced the appointment of Petra Kaufmann, M.D., M.S., F.A.A.N., as Chief Medical Officer. Dr. Kaufmann joins Ovid’s leadership team with responsibility for guiding clinical, medical, and regulatory strategy as the Company progresses a clinical pipeline of potential best- and first-in-class therapeutic candidates for conditions and symptoms driven by neuronal imbalance.

BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its fully human anti-IL-6 receptor (IL-6R) monoclonal antibody, TZLS-501, and related assets (together “TZLS-501”) via a spinout into a separate publicly traded company, to enhance the strategic focus of each company and to drive value for shareholders. Tiziana shareholders at the record date will retain value from TZLS-501 through the distribution in specie of shares in the new TZLS-501 listed entity.

Positioned for Adjusted EBITDA Profitability in the Second Half of 2025Strategic Digital Infrastructure Expansion Accelerates Diversified Growth, Targeting 11.3 EH/s Upon Full Deployment by 2026

PALO ALTO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Wealthfront, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced that it has launched the roadshow for its proposed initial public offering of its common stock. Wealthfront has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) to offer 34,615,384 shares of its common stock to the public. The offering consists of 21,468,038 shares of common stock being offered by Wealthfront and 13,147,346 shares of common stock being offered by existing stockholders (the “Selling Stockholders”). Wealthfront will not receive any proceeds from the sale of shares by the Selling Stockholders. In addition, Wealthfront intends to grant the underwriters a 30-day option to purchase up to an additional 5,192,308 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $12.00 to $14.00 per share. Wealthfront has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol “WLTH.”

MILAN, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Politecnico di Milano today held an inauguration ceremony for its 163rd academic year, where it focused on the values of responsibility, knowledge and cohesion in a highly polarised global context marked by tensions and profound change. The inauguration speech centred around the Politecnico’s role as an intermediary, a body with the ability to piece together the bigger picture; an institution that can turn change into something meaningful, through critical thinking and measured reflection on the role of technology. A ‘global vision’, European identity and science diplomacy feature prominently in the forthcoming Strategic Plan 2026-28. The most significant new steps include the launch of three BSc courses in English in the field of engineering.

Hole AN-25-10 Delivers Highest DTR Nickel Grade and Magnetic Concentrate Performance at RPM Zone; Company Plans to Announce Additional Drilling Around Hole 10 with Optimized Drilling Designed to Continue Eastward Expansion Toward Chrome Pond

FOND DU LAC, Wisc., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Mercury Marine, a global leader in marine propulsion systems and a division of Brunswick Corporation (NYSE: BC), has agreed to a new five-year exclusive supply agreement with Axopar Boats, the award-winning innovative Finnish boat manufacturer. This agreement not only extends a highly successful collaboration that has flourished for more than a decade but also reaffirms both companies’ unwavering commitment to redefining the boating experience for enthusiasts worldwide.

FOND DU LAC, Wisc., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Mercury Marine, a global leader in marine propulsion systems and a division of Brunswick Corporation (NYSE: BC), has announced the renewal of its exclusive supply agreement with Saxdor Yachts for the next five years. This agreement marks the continuation of a successful partnership that began six years ago, when Saxdor first entered the market and chose Mercury Marine as its sole engine supplier.

BEIJING, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Here Group Limited (NASDAQ: HERE) (“Here” or the “Company”), a pop toy company dedicated to creating beloved collectibles and trend-defining experiences, today announced its unaudited financial results for the first quarter of the fiscal year ending June 30, 2026 (the “first quarter of FY 2026”, which refers to the quarter from July 1, 2025 to September 30, 2025).

ZHUANGHE, China, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Right now, the first batch of winter strawberries from Guangmingshan Town in Zhuanghe City, Liaoning Province - situated within the renowned 39°N "golden planting belt" - has made its debut in the market. Blessed with exceptional natural conditions and ecological cultivation techniques, the strawberries grown here have become a striking "sweet economy" in the winter season. Local strawberry growers advanced the market launch by about two months compared with previous years through the use of intelligent temperature-controlled greenhouses and the application of frozen-seedling cultivation technology.

TORONTO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to announce 10 additional assay results from its 2025 drill program where drill hole GD-25-383 intersected 7.28 g/t Au over 8.00 meters, within 5.85 g/t Au over 10.00 meters in Eocene-aged granitoid dyke. The same interval also includes 9.20 g/t over 5.92 meters as well as 12.75 g/t Au over 4.02 meters, containing multiple occurrences of VG-NE that remains open at the Surebet Discovery on its 100% controlled Golddigger Property (the “Property”), Golden Triangle, British Columbia. Assays are still pending for 70 holes from this year’s exploration campaign, of which 55 (representing 79% of the pending holes) contain up to 12 occurrences of VG-NE; see images above and table below.

Berlin, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tacalyx, a privately held biotech company focused on developing novel TACA (Tumour Associated Carbohydrate Antigens) cancer therapies, announces the appointment of Jean Engela as Chief Executive Officer. Jean Engela brings more than two decades of experience in drug research and development, with a proven track record of leading organisations and assets through key phase transitions and scaling from discovery to clinical stages. The company’s co-founder and former CEO, Dr. Peter Sondermann, will continue to drive scientific innovation at Tacalyx as Chief Scientific Officer.

Kiel, GERMANY, December 2, 2025 – tiakis Biotech AG (“tiakis”), a clinical-stage biopharmaceutical company developing novel therapeutics for life-threatening pulmonary and cardiovascular diseases, today announced that the Company has successfully finalized a comprehensive data package to advance Tiprelestat into a Phase II clinical trial in Pulmonary Arterial Hypertension (PAH) by completing a preclinical GLP-tox study.

Built for staffing leaders and teams, Joveo’s AI Staffing Advisor delivers predictive, prescriptive, and actionable intelligence to improve fill rates and drive more revenue.

VICTORIA, Seychelles, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), took part in LALIGA's Youth Tournament in Manila, supporting one of Asia's most exciting grassroots football events focused on promoting sport, community, and camaraderie. Held from 14–16 November at the New Clark City Athletics Stadium, the tournament brought together more than 7,000 young players, families, and coaches for three days of competition, community spirit, and youth development.

Paris, France – 2 DECEMBER 2025 (08:30 CET)Enterome, a clinical-stage company pioneering OncoMimics™ peptides, a new class of off-the-shelf, multi-targeted in vivo immune therapies that induce a fast and potent expansion of memory T cells to fight cancer, today announces new survival analyses from Cohort 3 of the Phase 1/2 ROSALIE clinical trial. The data were reported at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting. The ROSALIE trial is evaluating Enterome’s OncoMimics™ immune therapy EO2401 in combination with immune checkpoint inhibitor nivolumab, with or without anti-VEGF therapy bevacizumab, in patients with glioblastoma at first progression/recurrence. Top-line data from the trial had previously been released in November 2023.

ENDEAVOUR TARGETS DISCOVERY OF 12-15 MILLION OUNCES OF RESOURCES OVER THE NEXT 5 YEARS 

Progress on share buyback programme

Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it has priced an underwritten public offering of 2,272,727 American Depositary Shares (“ADSs”), each representing one of its ordinary shares, at a public offering price of $154.00 per ADS. The Company has also granted the underwriters a 30-day option to purchase up to 340,909 additional ADSs from the Company at the public offering price, less underwriting discounts and commissions. The gross proceeds of the offering to the Company are expected to be approximately $350.0 million before deducting underwriting discounts and commissions and offering expenses payable by Belite Bio. All of the securities in the offering are to be sold by Belite Bio. The closing of the offering is expected to occur on or about December 3, 2025, subject to the satisfaction of customary closing conditions.

STRATFORD, Conn., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Top Dog Holdings is pleased to announce the acquisition of Dogfather Grooming, a leading mobile and salon grooming company serving pet families across the Northeast.

LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LAS VEGAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid, multicloud, and AI solutions company, today announced it is a recipient of a 2025 Geography and Global AWS Partner Award, recognizing leaders around the globe that are playing key roles in helping their customers drive innovation and build solutions on Amazon Web Services (AWS).

The nonprofit’s research shows stress related to finances has risen substantially

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

H.R. 3174 doubles SBA manufacturing loan limits from $5 million to $10 million

Nepean, Ontario , Dec. 01, 2025 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation (Nasdaq: OAKU) (“Oak Woods” or the “Company”) today announced that on November 25, 2025 it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Form 10-Q for the quarter ended September 30, 2025.

TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that it has completed and filed its interim financial statements for the period ended September 30, 2025, together with the related management's discussion and analysis and CEO and CFO certificates. Copies of these documents are available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

New report calls for coordinated leadership, sustained financing, and system-wide prevention to confront a global crisis affecting over one billion women and girls

ROAD TOWN, British Virgin Islands, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (NASDAQ: AUGO and B3: AURA33) (“Aura” or the “Company”) is pleased to announce that Aura, through a wholly owned subsidiary, has completed the previously announced acquisition from AngloGold Ashanti plc (“AngloGold”) of all of the issued and outstanding securities of Mineração Serra Grande S.A. (“MSG”), owner of the Mineração Serra Grande gold mine located in Crixás, in the state of Goiás, Brazil (the “Transaction”).

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) --

Strengthening MN-001’s Scientific Foundation and Clinical Outlook

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) --

CALGARY, Alberta, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announced that Enerflex Inc., a wholly owned subsidiary of Enerflex (the “Issuer”), has priced its previously announced private offering (the “Offering”) of $400 million in aggregate principal amount of 6.875% senior notes due 2031 (the “2031 Notes”). The 2031 Notes will be issued at par and will be guaranteed on a senior unsecured basis by the Company and certain of its subsidiaries. The offering of the 2031 Notes is expected to close on December 11, 2025, subject to customary closing conditions.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Synopsys, Inc. (NASDAQ:SNPS), CarMax, Inc. (NYSE:KMX), and Fiserv, Inc. (NYSE:FI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

BALA CYNWYD, Pa., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stride, Inc. (NYSE:LRN), Firefly Aerospace Inc. (NASDAQ:FLY), Six Flags Entertainment Corporation (NYSE:FUN), and Inspire Medical Systems, Inc. (NYSE:INSP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Molina Healthcare, Inc. (NYSE: MOH), aTyr Pharma, Inc. (NASDAQ:ATYR), and Marex Group PLC (NASDAQ:MRX) . Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”) announces that it has declared the following quarterly dividends per share on its preferred shares:

SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Currenc Group Inc. (Nasdaq: CURR) (“Currenc” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced its financial results for the six months ended June 30, 2025.

THE WOODLANDS, Texas, Dec. 01, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc., one of the nation’s leading homebuilders, has launched its Year-End Savings National Sales Event. Now through December 31, 2025, homebuyers can take advantage of significant savings, exclusive financing opportunities, and move-in-ready inventory across LGI Homes and its luxury brand, Terrata Homes.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”).

Operating expenses reduced 58% year-over-year and net loss improved 67% as Rivalry posts third consecutive quarter of revenue growth and completes debt restructure and recapitalization to enter 2026 on a strengthened foundation

Highlights

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount of convertible senior notes due 2032 (the “2032 notes”) and $1 billion aggregate principal amount of convertible senior notes due 2033 (the “2033 notes” and, together with the 2032 notes, the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). IREN also expects to grant the initial purchasers of the notes options to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $150 million principal amount of 2032 notes and $150 million principal amount of 2033 notes.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to commence a registered direct offering of ordinary shares (the “Offering”) to a limited number of purchasers. The Offering is being made pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The aggregate gross proceeds from the Offering are expected to approximate the aggregate cash consideration payable in connection with the Repurchase. In conjunction with any Repurchase of the Existing 2029 Convertible Notes (initial conversion price of $13.64) and Existing 2030 Convertible Notes (initial conversion price of $16.81), the principal amount of debt outstanding under the Existing Convertible Notes will be reduced accordingly and will be extinguished and, accordingly, will no longer be convertible into IREN’s ordinary shares, prior to maturity or otherwise.  The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, if at all, or as to the actual size or terms of the Offering.

EDINBURG, Va., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) announced that Ed McKay, Chief Executive Officer, will be participating in fiber panel discussions and investor meetings at conferences in New York, December 8 and 9, 2025.

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one of its ordinary shares. All of the securities in the offering are to be sold by Belite Bio. In addition, Belite Bio intends to grant the underwriters a 30-day option to purchase additional ADSs at the public offering price, less underwriting discounts and commission. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Evolution Global Acquisition Corp (the “Company”), a special purpose acquisition company formed as a Cayman Islands exempted company, today announced that commencing December 3, 2025, holders of the units sold in the Company’s initial public offering completed on November 12, 2025, may elect to separately trade the Class A ordinary shares of the Company and the warrants included in such units on the Nasdaq Global Market tier of  The Nasdaq Stock Market LLC (“Nasdaq”). Each unit consists of one Class A ordinary share of the Company, $0.0001 par value per share,  and one-half of one redeemable warrant, each whole warrant entitling the holder to purchase one Class A ordinary share upon exercise, at a price of $11.50 per share.

New 3300V and 2300V SiC products based on latest GeneSiC™ Trench-Assisted Planar technology and packaging innovations to augment efficiency and lifetime for AI data center, grid and energy infrastructure and industrial electrification including energy storage, renewable, and megawatt-scale fast-charging applications.

Hong Kong, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cre8 Enterprise Limited (Nasdaq: CRE) (“Cre8” or the “Company”), a Hong Kong-based integrated financial printing service provider, announced its unaudited financial results for the six months ended June 30, 2025 today.

ATLANTA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) (the “Company”) will release fiscal 2026 first-quarter results on Thursday, January 8, 2026 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call.

SAN CARLOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it has been selected for an oral presentation of its long-term icovamenib follow up data at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) taking place in Los Angeles, California on December 3-6, 2025. The Congress showcases cutting-edge developments from both emerging investigators and world-renowned leaders.

BERKELEY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that it will host an expert physician panel discussion during an ancillary event at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. The session will focus on how vispa-cel, Caribou’s allogeneic anti-CD19 CAR-T cell therapy, has the potential to expand patient access by enabling readily available CAR-T cell therapy care within sophisticated community hospitals and academic centers.

SAN CARLOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on November 26, 2025, the compensation committee of Biomea’s board of directors granted one new employee non-qualified stock options to purchase 7,500 shares of the Company’s common stock. The shares underlying each employee’s stock options will vest 1/16 on a quarterly basis over four years, subject to such employee’s continued employment with the Company on such vesting dates. The above-described award was made under Biomea’s 2023 Inducement Equity Plan (the “Plan”).

SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at the Bank of America CNS Therapeutics Conference, being held virtually on Monday, December 8, 2025, at 2:25 pm ET.

ST. PETERSBURG, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman and Chief Executive Officer, Michael Benstock, and President and Chief Financial Officer, Mike Koempel, will present at NobleCon21, Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference in Boca Raton, FL on Wednesday, December 3, 2025 at 12:30 PM Eastern Time. Following the event, a video replay will be available on the Events & Presentations page of the company's Investor Relations website here. Management will also host investor meetings throughout the day.

GREENWICH, Conn., Dec. 01, 2025 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for November 2025. LTL tonnage per day decreased 5.4%, as compared with November 2024, attributable to a year-over-year decrease of 2.2% in shipments per day and a decrease of 3.2% in weight per shipment. Actual results for November 2025 may vary from the preliminary results reported above.

FREMONT, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer and panel processing solutions for semiconductor and advanced packaging applications, today announced that it will be joining 14 other companies in collectively hosting the 14th Annual NYC Summit investor conference, being held Tuesday, December 16, 2025, at Mastro’s Steakhouse New York.